Vocabria is a brand name for the antiretroviral medication cabotegravir, which is used in the treatment and management of Human Immunodeficiency Virus (HIV) infection. As a part of a class of drugs known as integrase inhibitors, Vocabria works by blocking the virus's integrase enzyme. This action prevents the viral DNA from integrating into the genetic material of human cells, which is a critical step in the virus's replication process. By halting replication, cabotegravir helps to lower the amount of HIV in the body, thereby aiding in the control of the infection. Vocabria is often used in combination with other antiretroviral medications as part of a complete treatment regimen for HIV. It is known for its use in both the initiation of treatment in HIV-infected individuals and as part of ongoing maintenance therapy to manage the condition.